StartupsVenture

Jonathan Lim knows how to build biotechs for a sale. He auctioned off Ignyta ? where he was CEO ? to Roche last February for a tidy $1.7 billion, gaining a 74% premium on his stock. A few months before he also participated in the sale of Bonti to Aller… […]

As a Harvard professor with close ties to MIT?s Bob Langer, Omid Farokhzad has enjoyed a high-profile role in the Boston/Cambridge biotech community, where he?s participated in launching a lineup of startups. And now Farokhzad ? whose accomplishments e… […]